Finland
Orion Pharma is a leading Nordic pharmaceutical company with a century-long history of advancing well-being. Operating globally, the company develops, manufactures, and markets an extensive range of human and veterinary pharmaceuticals, encompassing both proprietary and generic medicines along with consumer health products.
The company differentiates itself through a strong emphasis on innovation, with core R&D areas focused on oncology and pain. Its proprietary treatments address a spectrum of critical conditions, including cancer, respiratory, and neurological diseases. This underscores Orion Pharma's commitment to being at the forefront of health solutions for complex medical challenges.
Backed by net sales of EUR 1,890 million as of 2025, and supported by a workforce of around 4,000 professionals worldwide, Orion Pharma combines its legacy of trusted expertise with continuous innovation to sustain its mission of building well-being on a global scale.
